Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.37 -0.13 (-3.71%)
As of: Oct 20, 2026 · 3:04 PM EDT

Apimeds Pharmaceuticals US (APUS) Market Capitalization (2025 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) recorded Market Capitalization of $13.58 million in Q2 2026, down 25.6% from $18.25 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Market Capitalization (2025 - 2026) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US reported Market Capitalization of $20.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,147.42 Bn 1,116.01 Bn 19.71 Bn
2 Johnson & Johnson 623.36 Bn 541.89 Bn 17.26 Bn
3 AbbVie 509.56 Bn 482.67 Bn 12.70 Bn
4 Merck 365.93 Bn 320.31 Bn 12.21 Bn
5 Novartis Ag 297.31 Bn 261.30 Bn 11.24 Bn
6 Astrazeneca 261.52 Bn 235.20 Bn 12.86 Bn
7 Amgen 235.01 Bn 190.41 Bn 7.24 Bn
8 Gilead Sciences 193.77 Bn 167.97 Bn 6.22 Bn
9 Pfizer 171.91 Bn 118.56 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.77 Mn -13.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.58 Mn
Dec 31, 2025 20.62 Mn
Sep 30, 2025 22.39 Mn
Jun 30, 2025 18.25 Mn
API Access

Apimeds Pharmaceuticals US Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=APUS&period=max&api_key=YOUR_API_KEY